Impact of rheumatoid arthritis on career progression, productivity, and employability: The PRET Study

Joint Bone Spine

Volumn 83, Issue 1, 2016, Pages 47-52

  Bertin, Philippe ^a   Fagnani, Francis ^b   Duburcq, Anne ^b   Woronoff, Anne Sophie ^c   Chauvin, Pierre ^d,e   Cukierman, Gabrielle ^f   Tropé Chirol, Sonia ^c   Joubert, Jean Michel ^f   Kobelt, Gisela ^d  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b CEMKA EVAL   (France)

^c ANDAR   (France)

^d INSTITUT PIERRE LOUIS D EPIDÉMIOLOGIE ET DE SANTÉ PUBLIQUE   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f UCB PHARMA   (Belgium)

Author keywords

Disability; Financial assistance; Part time work; Productivity; Rheumatoid arthritis; Sick leave; Work

Indexed keywords

ADULT; ARTICLE; CAREER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; EMPLOYABILITY; FEMALE; FRANCE; FUNCTIONAL DISEASE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; PARTTIME EMPLOYMENT; PERMANENT EMPLOYMENT; PRODUCTIVITY; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SOCIOECONOMICS; TEMPORARY EMPLOYMENT; WORK CAPACITY; WORK DISABILITY; ARTHRITIS, RHEUMATOID; CAREER MOBILITY; DISABLED PERSON; EMPLOYMENT; HEALTH STATUS INDICATOR; MIDDLE AGED; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA;

ARTHRITIS, RHEUMATOID; CAREER MOBILITY; CROSS-SECTIONAL STUDIES; DISABLED PERSONS; EFFICIENCY; EMPLOYMENT; FEMALE; FRANCE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES;

EID: 84987819733     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2015.05.001     Document Type: Article

References (38)

1. La polyarthrite rhumatoïde. 2012, Inserm http://www.inserm.fr/thematiques/circulation-metabolisme-nutrition/dossiers-d-information/la-polyarthrite-rhumatoide.
2. Lenssinck, M.L., Burdorf, A., Boonen, A., et al. Consequences of inflammatory arthritis for workplace productivity loss and sick leave: a systematic review. Ann Rheum Dis 72 (2013), 493–505.
3. Burton, W., Morrison, A., Maclean, R., et al. Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med (Lond) 56 (2006), 18–27.
4. Sokka, T., Kautiainen, H., Pincus, T., et al. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthritis Res Ther, 12, 2010, R42.
5. Koopmanschap, M.A., Rutten, F.F.H., A practical guide for calculating indirect costs of disease. Pharmacoeconomics 10 (1996), 460–466.
6. Verstappen, S.M., Boonen, A., Verkleij, H., et al. Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity. Ann Rheum Dis 64 (2005), 1754–1760.
7. Fex, E., Larsson, B.M., Nived, K., et al. Effect of rheumatoid arthritis on work status and social and leisure time activities in patients followed 8 years from onset. J Rheumatol 25 (1998), 44–50.
8. Kessler, R.C., Maclean, J.R., Petukhova, M., et al. The effects of rheumatoid arthritis on labor force participation, work performance, and healthcare costs in two workplace samples. J Occup Environ Med 50 (2008), 88–98.
9. Aronsson, G., Gustafsson, K., Dallner, M., Sick but yet at work. An empirical study of sickness presenteeism. J Epidemiol Community Health 54 (2000), 502–509.
10. Bansback, N., Zhang, W., Walsh, D., et al. Factors associated with absenteeism, presenteeism and activity impairment in patients in the first years of RA. Rheumatology (Oxford) 51 (2012), 375–384.
11. Braakman-Jansen, L.M., Taal, E., Kuper, I.H., et al. Productivity loss due to absenteeism and presenteeism by different instruments in patients with RA and subjects without RA. Rheumatology (Oxford) 51 (2012), 354–361.
12. Prasad, M., Wahlqvist, P., Shikiar, R., et al. A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective. Pharmacoeconomics 22 (2004), 225–244.
13. Eberhardt, K., Larsson, B.M., Nived, K., et al. Work disability in rheumatoid arthritis – development over 15 years and evaluation of predictive factors over time. J Rheumatol 34 (2007), 481–487.
14. Reisine, S., Fifield, J., Walsh, S., et al. Work disability among two cohorts of women with recent-onset rheumatoid arthritis: a survival analysis. Arthritis Rheum 57 (2007), 372–380.
15. Merkesdal, S., Ruof, J., Schoffski, O., et al. Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease. Arthritis Rheum 44 (2001), 528–534.
16. Wolfe, F., Hawley, D.J., The long term outcomes of rheumatoid arthritis: work disability: a prospective 18 year study of 823 patients. J Rheumatol 25 (1998), 2108–2117.
17. Allaire, S., Wolfe, F., Niu, J., et al. Current risk factors for work disability associated with rheumatoid arthritis: recent data from a US national cohort. Arthritis Rheum 61 (2009), 321–328.
18. Geuskens, G.A., Hazes, J.M., Barendregt, P.J., et al. Work and sick leave among patients with early inflammatory joint conditions. Arthritis Rheum 59 (2008), 1458–1466.
19. Wolfe, F., Allaire, S., Michaud, K., The prevalence and incidence of work disability in rheumatoid arthritis, and the effect of anti-tumor necrosis factor on work disability. J Rheumatol 34 (2007), 2211–2217.
20. Hone, D., Cheng, A., Watson, C., et al. Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States. Arthritis Care Res (Hoboken) 65 (2013), 1564–1572.
21. Hazes, J.M., Taylor, P., Strand, V., et al. Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol. Rheumatology (Oxford) 49 (2010), 1900–1910.
22. Kavanaugh, A., Smolen, J.S., Emery, P., et al. Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis. Arthritis Rheum 61 (2009), 1592–1600.
23. Rat, A.C., Boissier, M.C., Rheumatoid arthritis: direct and indirect costs. Joint Bone Spine 71 (2004), 518–524.
24. Kobelt, G., Woronoff, A.S., Richard, B., et al. Disease status, costs and quality of life of patients with rheumatoid arthritis in France: the ECO-PR Study. Joint Bone Spine 75 (2008), 408–415.
25. Enquête santé et itinéraire professionnel (SIP). 2013 voir le lien suivant: http://www.drees.sante.gouv.fr/IMG/pdf/sip_20130117_note_information_sip.pdf.
26. o 2005-102 du 11 février 2005 pour l’égalité des droits et des chances, la participation et la citoyenneté des personnes handicapées. 2005.
27. http://travail-emploi.gouv.fr/informations-pratiques,89/les-fiches-pratiques-du-droit-du,91/travailleurs-handicapes,1976/le-travail-en-milieu-ordinaire-et,12750.html.
28. Fries, J.F., Spitz, P., Kraines, G., et al. Measurement of patient outcome in arthritis. Arthritis Rheum 23 (1980), 137–145.
29. http://www.ameli.fr/employeurs/vos-demarches/arret-maladie/l-8217-arret-de-travail-pour-maladie/reprise-du-travail-a-temps-partiel.php 2015.
30. Filipovic, I., Walker, D., Forster, F., et al. Quantifying the economic burden of productivity loss in rheumatoid arthritis. Rheumatology 50 (2011), 1083–1090.
31. Eberhardt, K., Larsson, B.M., Nived, K., et al. Work disability in rheumatoid arthritis-development over 15 years and evaluation of predictive factors over time. J Rheumatol 34 (2007), 481–487.
32. Kobelt, G., Lindgren, P., Lindroth, Y., et al. Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis. Rheumatology (Oxford) 44 (2005), 1169–1175.
33. Barrett, E.M., Scott, D.G., Wiles, N.J., et al. The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study. Rheumatology (Oxford) 39 (2000), 1403–1409.
34. Puolakka, K., Kautiainen, H., Möttönen, T., et al. Predictors of productivity loss in early rheumatoid arthritis: a 5-year follow-up study. Ann Rheum Dis 64 (2005), 130–133.
35. Fautrel, B., Joubert, J.M., Cukierman, G., et al. Rheumatoid arthritis (RA), biological agents uptake and comorbidities in France: analysis of a national claims database. 2013 http://www.abstracts2view.com/eular/view.php?nu=EULAR13L_THU0512&terms.
36. o 005, 2013.
37. o 40, 2011.
38. Source: http://www.insee.fr/fr/ffc/docs_ffc/FPORSOC13h_D2_emploi.pdf. 2013.